kneat.com, inc.

kneat.com, inc. is a global leader in digital validation and quality process automation, developing and marketing software for regulated data-intensive processes, primarily within the life sciences industry. The company's mission is to empower regulated organizations to confidently develop, manufacture, and deliver products to the highest safety standards, by enhancing speed, intelligence, quality, and compliance while reducing inefficiency, error, and risk. Its global headquarters are located in Limerick, Ireland, with a Canadian legal domicile in Ottawa, Ontario, and additional offices across North America, Europe, and Asia.

The company's flagship product is Kneat Gx, a cloud-based, configurable Software-as-a-Service (SaaS) platform designed for validation lifecycle management and testing. Kneat Gx enables organizations to digitize and manage various validation processes, including equipment, computer system, cleaning, and process validation, in a compliant, paperless environment. Beyond its core software, Kneat offers a suite of services such as system implementation, process optimization, digital validation training, data migration, and technical account management. The platform serves a broad spectrum of the life sciences sector, including pharmaceutical, biotechnology, medical device, consumer health, and contract manufacturing organizations, and is trusted by 8 of the top 10 global pharmaceutical companies.

As of June 8, 2026, kneat.com, inc. announced it has entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, L.P., a software-focused investment firm, in an all-cash transaction valued at approximately C$650 million. This acquisition, expected to close in Q3 2026, will transition Kneat from a publicly traded entity to a privately held company. The company continues to be recognized for its market leadership, having been ranked as a top performer in pharma and biotech software by G2. Eddie Ryan serves as the CEO and Co-Founder.